COLUMBUS, Ohio, July 31 (HSMN NewsFeed) — PharmaForce, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone Sodium Phosphate and Betamethas…
Biopharmaceuticals, Generics, FDA
PharmaForce, Betamethasone, Schering, Celestone, Soluspan

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP”
Leave a Comment